U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX11208435: 04-P01-tissue
1 ILLUMINA (NextSeq 500) run: 7,908 spots, 1.2M bases, 569,719b downloads

Design: DNA extracts (30-200 ng) were sheared to 250 bp fragments. Libraries were prepared using the KAPA Hyper Prep Kit (KAPA Biosystems) following the manufacturer's protocol.
Submitted by: 3D Medicines Inc., Shanghai, China
Study: ctDNA and cfDNA in the Perioperative Period to Predict the Recurrence Risk in Early NSCLC
PRJNA740302 • SRP325364 • All experiments • All runs
show Abstracthide Abstract
In this study, dynamic changes of ctDNA and cfDNA in the perioperative period of NSCLC were used to explore the possibility of them as biomarkers to indicate the risk of recurrence. And we found that the cfDNA levels are raised by the operation overall, but will be polarized after surgery in 7 days. Patients with perioperative elevated cfDNA may have a higher risk of recurrence. We may have identified a biomarker that is more readily available than ctDNA to predict the risk of NSCLC recurrence after surgery.
Sample: 04-P01-tissue
SAMN19838050 • SRS9262771 • All experiments • All runs
Organism: Homo sapiens
Library:
Name: 38983S01
Instrument: NextSeq 500
Strategy: Targeted-Capture
Source: GENOMIC
Selection: Hybrid Selection
Layout: PAIRED
Runs: 1 run, 7,908 spots, 1.2M bases, 569,719b
Run# of Spots# of BasesSizePublished
SRR148931077,9081.2M569,719b2021-06-24

ID:
14950579

Supplemental Content

Related information

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...